Cargando…
Mammaglobin 1 mediates progression of trastuzumab‐resistant breast cancer cells through regulation of cyclins and NF‐κB
Overexpression of human epidermal growth factor receptor 2 (HER2) in various cancers is correlated with poor patient survival. Trastuzumab, a recombinant humanized monoclonal antibody against HER2, has been considered to be a first‐line therapy for HER2‐positive breast cancer patients, but its usefu...
Autores principales: | Kusumastuti, Ratih, Kumagai, Yuji, Ishihara, Seiichiro, Enomoto, Atsushi, Murakami, Takashi, Yasuda, Motoaki, Haga, Hisashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527592/ https://www.ncbi.nlm.nih.gov/pubmed/35945910 http://dx.doi.org/10.1002/2211-5463.13468 |
Ejemplares similares
-
The interferon-β/STAT1 axis drives the collective invasion of skin squamous cell carcinoma with sealed intercellular spaces
por: Kumagai, Yuji, et al.
Publicado: (2022) -
Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells
por: Ishihara, Seiichiro, et al.
Publicado: (2015) -
In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells
por: Hassan, Eman M., et al.
Publicado: (2017) -
Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors
por: Ishihara, Seiichiro, et al.
Publicado: (2022) -
The LINC00365/SCGB2A1 (Mammaglobin B) Axis Down-Regulates NF-κB Signaling and Is Associated with the Progression of Gastric Cancer
por: Yan, Xiao-Yu, et al.
Publicado: (2020)